Ascorbate protects liver from metabolic disorder through inhibition of lipogenesis and suppressor of cytokine signaling 3 (SOCS3)

BACKGROUND: Fatty liver is a reversible status, but also an origin stage to develop to other metabolic syndromes, such as diabetes and heart disease that threatens public health worldwide. Ascorbate deficiency is reported to be correlated with increasing risks for metabolic syndromes, but whether as...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yingying, Wu, Yuhang, Xiong, Yue, Tao, Jiawang, Pan, Tingcai, Tan, Shenglin, Gao, Ge, Chen, Yan, Abbas, Nasir, Getachew, Anteneh, Zhuang, Yuanqi, You, Kai, Yang, Fan, Li, Yin-xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057613/
https://www.ncbi.nlm.nih.gov/pubmed/32158492
http://dx.doi.org/10.1186/s12986-020-0431-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057613/
https://www.ncbi.nlm.nih.gov/pubmed/32158492
http://dx.doi.org/10.1186/s12986-020-0431-y

Ejemplares similares